Ad
related to: health devices journal articles list of drugs
Search results
Results From The WOW.Com Content Network
This is a list of notable medical and scientific journals that publish articles in pharmacology and the pharmaceutical sciences This is a dynamic list and may never be able to satisfy particular standards for completeness.
Medical journals are published regularly to communicate new research to clinicians, medical scientists, and other healthcare workers. This article lists academic journals that focus on the practice of medicine or any medical specialty. Journals are listed alphabetically by journal name, and also grouped by the subfield of medicine they focus on.
Journal of Experimental Pharmacology; Journal of Healthcare Leadership; Journal of Hepatocellular Carcinoma; Journal of Inflammation Research; Journal of Multidisciplinary Healthcare; Journal of Neurorestoratology † Journal of Pain Research; Journal of Receptor, Ligand and Channel Research † Journal of Parkinsonism and Restless Legs Syndrome
Health Services Management Research; Human Resources for Health; Journal for Healthcare Quality; Journal of Healthcare Management; Journal of Innovation in Health Informatics; Journal of Medical Marketing
Many drugs have more than one name and, therefore, the same drug may be listed more than once. Brand names and generic names are differentiated by capitalizing brand names. See also the list of the top 100 bestselling branded drugs , ranked by sales.
Misoprostol is approved for medical abortion regimens when administered at the office, but clinicians often give abortion patients the drug to be taken at home. [ 15 ] Modafinil is a central nervous system (CNS) stimulant medication used to treat sleepiness due to narcolepsy , shift work sleep disorder , and obstructive sleep apnea .
It covers health policy and development, assessment of clinical and cost-effectiveness, and implementation of all types of medical technology, including drugs, devices, diagnostics, and eHealth platforms. The journal is abstracted and indexed in Scopus, [1] Social Sciences Citation Index, [2] and Embase. [3]
Drug Manufacturer Indication Adagrasib: In combination with cetuximab for the treatment of adults with KRAS G12C mutated locally advanced or metastatic colorectal cancer who have been previously treated with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy [2]